INSIGHTS ON CELL & GENE MANUFACTURING AND LOGISTICS

• Is Your AI Model Trustworthy And Credible In GMP Processes?

  Credibility and trustworthiness in AI models are related but distinct attributes. If you're using them in GMP manufacturing, you should understand the difference.

• The Manufacturing Reckoning Behind CAR-T's Hottest Race

  In vivo CAR-T scales patient access and cuts timelines but turns biological hurdles into complex manufacturing demands. Precise assays and tight raw material controls are vital for regulatory success.

• How To Choose The Right CDMO

  Advanced therapy manufacturing requires deep biological expertise. Choosing a partner with translational experience and a robust CMC strategy is vital to navigating complex regulatory reviews.

• 5 Common Pitfalls In CGT Facility Design Planning And Implementation

  With shifting needs and requirements in advanced therapy manufacturing, embedding infrastructure flexibility is vital. Discover how to balance these variables for long-term success.

• Scalable rAAV9 Production Using Advanced Cell Lines And Bioreactors

  Progress in gene therapy manufacturing is being driven by improved cell line performance and scalable bioprocessing. See how high-density growth helps streamline development to larger-scale production.

• In Vivo Gene Editing Is Moving From Promise To Proof

  CGT is shifting from technical promise to clinical execution as in vivo approaches reach an inflection point where delivery, durability, specificity, and manufacturability will determine whether the field can turn breakthrough science into safe, scalable, repeatable therapies.

• New Robot-Compatible Sterile Connectors Enhance Cell Therapy Manufacturing

  Discover how automating sterile fluid transfers removes human contamination risks, solves operator shortages, and reduces cell therapy manufacturing costs by up to 74%.

• Using Residual DNA Quantification Data To De-Risk mAb Development

  Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

• Support Growth: A Solid Support Growth Material For Cell Culture

  Higher cell density and improved process consistency start with the right growth environment. This structured cell attachment helps streamline scale-up with unique protection to maintain strong viability across demanding bioprocess applications.

• Universal Controller For Cell Culture And Microbiology Applications

  Seamless scale-up starts with adaptable bioprocessing tools. Flexible benchtop systems with advanced control and automation help maintain consistency, reduce risk, and accelerate the transition from early development to scalable, production-ready workflows.